Cargando…
Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy
OBJECTIVES: Polycystic liver disease (PLD) is characterized by growth of hepatic cysts, causing hepatomegaly. Disease severity is determined using total liver volume (TLV), which can be measured from computed tomography (CT). The gold standard is manual segmentation which is time-consuming and requi...
Autores principales: | Aapkes, Sophie E., Barten, Thijs R. M., Coudyzer, Walter, Drenth, Joost P. H., Geijselaers, Ivo M. A., ter Grote, Sterre A. M., Gansevoort, Ron T., Nevens, Frederik, van Gastel, Maatje D. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121488/ https://www.ncbi.nlm.nih.gov/pubmed/36640173 http://dx.doi.org/10.1007/s00330-022-09346-6 |
Ejemplares similares
-
Estrogens in polycystic liver disease: A target for future therapies?
por: Aapkes, Sophie E., et al.
Publicado: (2021) -
Tamoxifen for the treatment of polycystic liver disease: A case report
por: Aapkes, Sophie E., et al.
Publicado: (2021) -
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
por: Aapkes, S. E., et al.
Publicado: (2022) -
Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life
por: Duijzer, Renée, et al.
Publicado: (2022) -
The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study
por: Knol, Martine G E, et al.
Publicado: (2021)